ClinicalTrials.gg
DrugBiological

Pegfilgrastim clinical trials

Also written Neulasta, DA-3031 and CHS-1701.

studies test it
136
open now
10
in phase 3
23
first study started
2000

How each study uses pegfilgrastim is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the pegfilgrastim studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
31 Jan 2002 · NEULASTA · BLA 125031 (FDA, Drugs@FDA)
European Union
22 Aug 2002 · Neulasta · EMEA/H/C/000420 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Pegfilgrastim
75
PEG-G-CSF
6
Filgrastim SD-01
5
lipegfilgrastim
4
GCSF-SD01
4

Brand

Neulasta
28

Development codes

DA-3031
3
CHS-1701
3
INTP5
2
MSB11455
2
XM22
1
SD-01
1
QL0605
1

Other names

Peg-Filgrastim
1

Biosimilars

PF-06881894
2
HSP-130
2
LA-EP2006
2
Pegcyte
1
Udenyca®
1

Studies by the year they started

132 studies that test it; most in 2003 (13)

Studies that test pegfilgrastim, by start year
YearStudies
20003
20014
20026
200313
20043
20057
20069
20075
20089
20091
20103
20111
20128
20133
20144
201510
20168
201712
20184
20192
20202
20215
20225
20243
20252

By phase

A phase 1/2 study counts in both.

Early Phase 1
2
Phase 1
31
Phase 2
72
Phase 3
23
Phase 4
7
No phase
7

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 57 · Other 79

Amgen (15) · M.D. Anderson Cancer Center (7) · Memorial Sloan Kettering Cancer Center (4) · Pfizer (4) · Gynecologic Oncology Group (4) · National Cancer Institute (NCI) (3) · Kyowa Kirin Co., Ltd. (3) · Spectrum Pharmaceuticals, Inc (3)

Often tested with

Tested in the same studies.

Filgrastim (15) · Docetaxel (14) · Cyclophosphamide (11) · Cisplatin (10) · Doxorubicin (9) · Carboplatin (9) · Etoposide (8) · Paclitaxel (8)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 1 phase 3 study under way

Pegfilgrastim is the comparator. A study of two new drugs counts under both.

  • 1NPI 2358 · BeyondSpring Pharmaceuticals Inc.
Reaching primary completion within a year · 7, 3 in phase 3

Studies that test pegfilgrastim, phase 3 first.

Studies

Open first, then newest update. How each study uses pegfilgrastim is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 136

See all 136 studies that test pegfilgrastim →

Given beside what is tested · 123 — pegfilgrastim is usual care or a partner of the new treatment

Showing 20 of 123.

As the comparator · 16 — what is tested is compared with pegfilgrastim

Codes

What other systems call pegfilgrastim · ClinicalTrials.gg INT004446

  • MeSH (NLM) C455861pegfilgrastimConfirmed NLM, Wikidata
  • UNII (FDA) 3A58010674PEGFILGRASTIMConfirmed FDA, NLM, Wikidata
  • RxNorm 338036Confirmed FDA, Wikidata
  • Wikidata Q1592932pegfilgrastimConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C1854PegfilgrastimConfirmed FDA, Wikidata
  • DrugBank DB00019One source Wikidata

Also registered as lipegfilgrastim (UNII 4AWF0N6QV3 · RxNorm 1440046).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.